FDA Investigates Diamond Shruumz Edibles: At Least 69 People Hospitalized After Consuming Psilocin-Laced Products

Denver, Colorado, Colorado United States of America
At least 69 people hospitalized after consuming Diamond Shruumz edibles
Consumers advised to throw away or return recalled products for a full refund
Diamond Shruumz products contain psilocin
FDA investigating Diamond Shruumz following reports of illnesses and hospitalizations across multiple states
Symptoms include seizures, loss of consciousness, confusion, sleepiness, high and low blood pressure, abnormal heart rates, agitation, nausea and vomiting
FDA Investigates Diamond Shruumz Edibles: At Least 69 People Hospitalized After Consuming Psilocin-Laced Products

In recent news, the Food and Drug Administration (FDA) has launched an investigation into Diamond Shruumz brand microdosing edibles following reports of illnesses and hospitalizations across multiple states. The FDA warns consumers not to purchase or consume any Diamond Shruumz products due to potential health risks.

According to various sources, including the Miami Herald and CBS News, at least 69 people have fallen ill after consuming Diamond Shruumz gummies and chocolate bars. Symptoms include seizures, loss of consciousness, confusion, sleepiness, high and low blood pressure, abnormal heart rates, agitation, nausea and vomiting.

The FDA is currently monitoring the recall process initiated by Prophet Premium Blends, the parent company of Diamond Shruumz. The agency advises consumers to throw away or return any recalled products for a full refund.

Denver officials have confirmed that some Diamond Shruumz gummies contain psilocin, a hallucinogenic substance found in certain types of mushrooms and classified as a Schedule I controlled substance by the Drug Enforcement Administration (DEA). Consumers cannot rely on product labels to determine what they are consuming as no one is currently regulating these products.

The Centers for Disease Control and Prevention (CDC) reported five hospitalizations between September 2023 and June 2024 after people consumed gummies labeled to contain Amanita muscaria, a mushroom that can cause undesired symptoms but is legal. However, the presence of psilocin in Diamond Shruumz products raises concerns about their safety.

The FDA urges consumers to be cautious when purchasing edibles and to consult with healthcare professionals if they experience any adverse effects. The agency also encourages companies to ensure transparency regarding their ingredients and manufacturing processes.


Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image
Article Image

Confidence

91%

Doubts
  • Are all reported cases definitively linked to Diamond Shruumz products?
  • Is the number of hospitalizations an accurate representation of the total affected population?

Sources

85%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
(Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

Dozens sick in 28 states from Diamond Shruumz 'microdosing' edibles

Business Insider Lauren Edmonds Sunday, 21 July 2024 20:22
  • Unique Points
    • Diamond Shruumz's website claimed its products did not contain psilocybin or any other scheduled drugs, but tests conducted by the University of Virginia found psilocin in their Sour Peach Apple and Rainbow gummies.
    • The CDC study mentioned that five people underwent hospital evaluations between September 2023 and June 2024 after eating gummies labeled to contain Amanita muscaria; although it can cause undesired symptoms, the report said it's legal.
    • Diamond Shruumz recalled all of its products, including gummies and chocolate bars, in June after illnesses continued to rise across the country.
    • The FDA would monitor Prophet Premium Blends, the company behind Diamond Shruumz, during its recall process and advised consumers not to purchase or consume any Diamond Shruumz-brand products.
  • Accuracy
    • The FDA first alerted the public about Diamond Shruumz products after eight people in four states fell ill from consuming the retailer’s microdosing chocolate bars.
    • As of July 15, there have been 69 illnesses across 28 states related to Diamond Shruumz products, with 60 of those individuals seeking medical care, 36 being hospitalized, and one potentially associated death under investigation.
    • Diamond Shruumz’s website claimed its products did not contain psilocybin or any other scheduled drugs.
    • University of Virginia found psilocin in Diamond Shruumz Sour Peach Apple and Rainbow gummies.
    • Five people underwent hospital evaluations between September 2023 and June 2024 after eating gummies labeled to contain Amanita muscaria, although it can cause undesired symptoms, the report said it’s legal.
    • Related stories advise that persons purchasing products advertised as psychedelic or nootropic mushroom gummies should be aware that package labels might not accurately represent the contents and these products could contain substances that might produce unexpected and potentially toxic effects.
  • Deception (50%)
    The article reports on the FDA's investigation into Diamond Shruumz products after multiple people fell ill from consuming them. The author states that as of July 15, there have been 69 reported illnesses across 28 states. However, the article also mentions that five people were hospitalized after eating gummies labeled to contain Amanita muscaria, which is legal in some states. This selective reporting of details supports the author's position that Diamond Shruumz products are dangerous and mislabeled, but it does not provide a complete picture of the situation. The article also implies that psilocin, a psychedelic substance found in Diamond Shruumz gummies, is illegal without disclosing that it is only illegal in certain states. This emotional manipulation and sensationalism could mislead readers into believing that all Diamond Shruumz products are dangerous and illegal when that may not be the case.
    • Related stories Persons who purchase products advertised as psychedelic or nootropic mushroom gummies should be aware that package labels might not accurately represent the contents and that these products could contain substances that might produce unexpected and potentially toxic effects.
    • The FDA now says that as of July 15, those numbers have ballooned to 69 illnesses across 28 states.
    • The agency said it would monitor Prophet Premium Blends, the company behind Diamond Shruumz, during its recall.
  • Fallacies (85%)
    The article contains a few instances of inflammatory rhetoric and appeals to authority. It also presents a dichotomous depiction of Diamond Shruumz products as either safe or containing dangerous substances without providing the full context.
    • . . . eight people in four states fell ill from consuming the retailer’s microdosing chocolate bars.
    • The FDA now says that as of July 15, those numbers have ballooned to 69 illnesses across 28 states.
    • Sixty (60) of the 69 people have reported seeking medical care, 36 have been hospitalized, and there is one potentially associated death under investigation.
    • Diamond Shruumz’s website said its products do not contain psilocybin or any other scheduled drugs.
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (100%)
    None Found At Time Of Publication

76%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
(Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

Legal mushroom gummies found to contain illegal hallucinogens

Fortune Media Inc. Beth Greenfield Thursday, 18 July 2024 00:00
  • Unique Points
    • University of Virginia Medical Center found illegal and potentially harmful ingredients in some magic mushroom gummies
    • Diamond Shruumz initiated a recall due to serious adverse effects from their products
    • Three out of five tested brands contained hallucinogenic substances according to UVA’s Blue Ridge Poison Center
  • Accuracy
    • People equate ‘legal’ with ‘safe’, but these products are not regulated and can contain unlabeled substances causing undesired symptoms
  • Deception (30%)
    The article contains selective reporting as it only mentions three out of the five brands that were tested and found to contain illegal substances. It also uses emotional manipulation by describing the gummies as 'magic mushrooms' and 'brain-health mushroom gummies', implying that they are harmless or even beneficial, when in fact they contain illegal and potentially harmful ingredients. The article also sensationalizes the story by using phrases like 'poison control experts have just announced' and 'amidst an unrelated investigation by the FDA'.
    • Of those, three were found to contain the hallucinogenic substances.
    • The spell has been broken on some magic mushrooms this week, as poison control experts at the University of Virginia Medical Center have just announced they’ve found illegal, potentially harmful ingredients in legal ‘brain-health’ mushroom gummies widely sold at smoke shops and convenience stores.
  • Fallacies (80%)
    The author uses inflammatory rhetoric by describing the mushroom gummies as 'magic mushrooms' and 'illegal' multiple times, even though they are decriminalized in some places. The author also makes an appeal to authority by quoting experts from the University of Virginia Medical Center and the Food and Drug Administration. However, no formal or dichotomous fallacies were found.
    • ]The spell has been broken on some magic mushrooms this week[.
    • Among the unexpected findings, prompted by five emergency-room visits, were psilocybin and psilocin[.
    • This news comes on the heels of a June recall on such products from one particular brand, Diamond Shruumz[.
    • The FDA issued an update, warning that...the products are still on shelves at several smoke/vape shops, and at retailers that sell hemp-derived products.[
    • At UVA, researchers analyzing the gummies found caffeine, ephedrine, and kratom along with the psilocybin[.
    • A series of five emergency room cases at UVA Health Medical Center between September and June prompted poison experts to test five different brands of the products sold in Central Virginia gas stations and smoke shops[.
  • Bias (80%)
    The author expresses a clear bias against the sale and consumption of these mushroom gummies due to their potentially harmful ingredients. She uses language that depicts the consumers as seeking 'a different type of experience' or 'a different type of high', implying that they are looking for something extreme or unreasonable. The author also quotes a poison expert who expresses concern about the lack of regulation and potential for unlabeled substances in these products.
    • But that could not be more false.
      • People tend to equate ’legal’ with ’safe’, which is not necessarily the case. These products are not regulated and can contain any number of unlabeled substances which, when consumed, can cause undesired symptoms.
      • Site Conflicts Of Interest (100%)
        None Found At Time Of Publication
      • Author Conflicts Of Interest (100%)
        None Found At Time Of Publication

      93%

      The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
      (Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

      A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

      Recalled Diamond Shruumz gummies contained illegal controlled substance, testing finds

      CBS News Site: https://www.cbsnews.com/articles/about-us/ Alexander Tin Sunday, 21 July 2024 20:24
      • Unique Points
        • Denver officials have confirmed that Diamond Shruumz brand gummies contain psilocin, a schedule I controlled substance.
        • People may have unknowingly consumed magic mushrooms through these gummies.
        • The Blue Ridge Poison Center at the University of Virginia discovered the presence of psilocin in the recalled gummies through testing.
        • Psilocin is a hallucinogenic substance found in some types of mushrooms and is illegal under DEA regulations.
        • Consumers cannot rely on product labels to determine what they are consuming as no one is currently regulating these products.
      • Accuracy
        • At least 69 illnesses and 36 hospitalizations have been linked to consuming Diamond Shruumz edibles including chocolates and cones as well as gummies.
        • Diamond Shruumz recalled all of its products, including gummies and chocolate bars, in June after illnesses continued to rise across the country.
      • Deception (100%)
        None Found At Time Of Publication
      • Fallacies (100%)
        None Found At Time Of Publication
      • Bias (95%)
        The author does not demonstrate any clear bias in the article. However, there is a disproportionate number of quotes that reflect the negative consequences of consuming unregulated gummies containing psilocin and other undisclosed substances. This could potentially be seen as an implicit bias against these types of products.
        • At least 69 illnesses and 36 hospitalizations have been linked to consuming Diamond Shruumz ‘edibles,’ the CDC says, which included chocolates and cones as well as gummies. Multiple hospitalizations have been in children.
          • Instead of psilocybin, some of the gummies they tested had been labeled as claiming to use legal extracts of a mushroom called Amanita muscaria. That mushroom can cause hallucinogenic effects, but are rarely ingested because they cause side effects like seizures and gastrointestinal upset.
            • People eating some of the now-recalled Diamond Shruumz brand candies may also have been getting a dose of an illegal substance from magic mushrooms, testing by a Virginia poison control center has confirmed.
            • Site Conflicts Of Interest (100%)
              None Found At Time Of Publication
            • Author Conflicts Of Interest (100%)
              None Found At Time Of Publication

            95%

            The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
            (Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

            A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

            Stay away: Microdosing edibles recalled during FDA investigation of illness, death

            Miami Herald Adlai Coleman Sunday, 21 July 2024 20:25
            • Unique Points
              • The FDA is investigating Diamond Shruumz microdosing candies that have sickened 69 people across 28 states, including one death.
              • All Diamond Shruumz products were recalled by their parent company, Prophet Premium Blends.
              • Symptoms of ingesting the candies include seizures, loss of consciousness, confusion, sleepiness, high and low blood pressure, abnormal heart rates, agitation, nausea and vomiting.
              • The FDA warns not to buy or eat any flavor of Diamond Shruumz edibles. Customers who have purchased the recalled products can return them for a full refund.
              • Symptoms have continued to rise through early July with nearly 10 new cases reported between July 9 and July 16.
            • Accuracy
              • As of July 15, there have been 69 illnesses across 28 states related to Diamond Shruumz products, with 60 of those individuals seeking medical care, 36 being hospitalized, and one potentially associated death under investigation.
              • Diamond Shruumz recalled all of its products, including gummies and chocolate bars, in June after illnesses continued to rise across the country.
            • Deception (100%)
              None Found At Time Of Publication
            • Fallacies (85%)
              The article contains inflammatory rhetoric and appeals to authority. It also presents a dichotomous depiction of the situation.
              • . . . the edibles have been linked to 36 hospitalizations and even a possible death.
              • Despite the warning in June and the subsequent recall, reports of illness have continued to rise through early July, with nearly 10 new cases reported between July 9 and July 16, according to the FDA website.
              • The FDA also warned that, as of July 16, the products were still on sale at various stores throughout the country.
            • Bias (100%)
              None Found At Time Of Publication
            • Site Conflicts Of Interest (100%)
              None Found At Time Of Publication
            • Author Conflicts Of Interest (100%)
              None Found At Time Of Publication

            74%

            The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
            (Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

            A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

            Mushroom edibles are rising in popularity. It's hard to say what's in them.

            NBC News Digital Sunday, 21 July 2024 20:27
            • Unique Points
              • They claim to offer a variety of mind-altering experiences
              • The effects don’t necessarily stem from psilocybin
              • Musciimol, a hallucinogenic compound in the mushroom, can alter mood, perception and behavior
            • Accuracy
              • No one knows for sure what’s going into these products
            • Deception (30%)
              The article makes several statements that could be considered deceptive or misleading. First, it states that 'often it's a mushroom called Amanita muscaria', but then goes on to say that 'what's going into many of these products remains an open question'. This is a lie by omission as the article fails to mention that there is no evidence or proof that this specific mushroom is actually being used in the products. Additionally, the article states that 'People might be taking a different dose from what's on the label or think they're taking one thing and actually taking something else entirely', but it does not provide any evidence to support this claim. This could be considered sensationalism as it creates fear and uncertainty around the safety of these products without providing concrete evidence.
              • Often it's a mushroom called Amanita muscaria
              • People might be taking a different dose from what's on the label or think they're taking one thing and actually taking something else entirely
            • Fallacies (85%)
              The article contains several informal fallacies and a potential appeal to authority. The author states that 'often it's a mushroom called Amanita muscaria', but does not provide any evidence or citation for this claim. This is an example of an unsubstantiated claim, which is an informal fallacy. Additionally, the author quotes Dr. Avery Michienzi stating that 'They're unregulated, and no one knows what they're putting in them', implying that the lack of regulation is a problem. However, this statement could be interpreted as an appeal to authority as it implies that because Dr. Michienzi is an expert, her opinion on the issue should be trusted without question. It is important to remember that while experts can provide valuable insights, their opinions should not be taken as absolute truth.
              • Often it's a mushroom called Amanita muscaria
              • They're unregulated, and no one knows what they're putting in them
            • Bias (95%)
              The article does not demonstrate any clear bias towards a specific political, religious, ideological or monetary position. However, it does highlight the risks associated with unregulated mushroom edibles and the potential for consumers to be misled by inaccurate product labels. The author provides examples of illnesses caused by these products and mentions the ongoing investigation by regulatory agencies.
              • Indeed, with the rise in popularity, there has also been a growing number of alarming reports of people being sickened by edible mushroom products.
                • They're unregulated, and no one knows what they're putting in them.
                • Site Conflicts Of Interest (100%)
                  None Found At Time Of Publication
                • Author Conflicts Of Interest (0%)
                  None Found At Time Of Publication